Biogen

Companies Biogen

News Biogen

• Biogen Idec and Sobi announce positive top-line results from phase 3 study in hemophilia B

  Biogen Idec and Swedish Orphan Biovitrum (Sobi)announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor candidate in people with hemophilia B. Hemophilia B is a rare inherited disorder that impairs blood coagulation.Top-line results from B-LONG, a gl more

• Biogen Idec and Sobi Initiate Global Clinical Trials of Long-Lasting Hemophilia A and B Product Candidates in Children

  Biogen Idec and Swedish Orphan Biovitrum announced the initiation of two global pediatric clinical trials of the companies' long-lasting recombinant Factor VIII and Factor IX Fc fusion proteins (rFVIIIFc and rFIXFc) in hemophilia A and B.rFVIIIFc and rFIXFc are fully-recombinant clotting factors dev more

• Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis

  Biogen Idec and Abbott announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial designed to evaluate the investigational compound daclizumab high-yield process (DAC HYP) in people with relapsing-remitting multiple sclerosis (RRMS) over one year. Results showe more

Market studies Biogen

• Zydus Cadila Healthcare Limited (532321) - Financial and Strategic SWOT Analysis Review

  Zydus Cadila Healthcare Limited (Zydus Cadila) is a publicly traded health care providing company, engaged in discovery, development, production and marketing of healthcare products. The company is principally focused on active pharmaceutical ingredient (API) to formulations, cosmeceuticals and anim more

Websites Biogen